| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |